Development of the Retinofugal Pathway in Birds and Mammals: Evidence for a common 'timetable'. (Part 1 of 2)Dreher B. · Robinson S.R.
Department of Anatomy, University of Sydney, NSW, Australia
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
We have compared changes in axon numbers in the developing optic nerves of eight homeotherms (seven mammals and one bird) using data from the available literature and our own material. The proportion of axons lost during development is smaller in the chick (35%) than in mammals (54–74%). The relative magnitude of this loss does not correlate with the extent of the binocular visual field or the size of the retinofugal ipsilateral projection. The timing of developmental events in the retinofugal pathway was compared as a proportion of the period between conception and eye opening (percentage of the 'caecal period', CP). In eutherian mammals, retinal ganglion cells and their target neurons are generated between 30 and 49% of CP (a duration of 19% of CP). In homeotherms, a phase of rapid axon generation begins around 38% of CP and the peak number of axons is reached at about 56 % of CP (a duration of 18 % of CP). A phase of rapid axon loss begins thereafter, and in most species it ends at about 74% of CP (a duration of 18% of CP), the rate of rapid axons loss being about half the rate of rapid axon generation. The similarity in relative timing (homochrony), like the similarity in the relative magnitude of the axon loss, suggests that cell generation and loss in the retinofugal pathway are influenced by a mechanism common to all homeotherms. We propose that in homeotherms each cohort of retinal ganglion cells is numerically matched with a group of target cells that is at an appropriate stage of maturation ('temporal matching' hypothesis). About twice as many ganglion cells are produced in each cohort than are needed, and their survival is determined by natural selection.
© 1988 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.